Paediatria Croatica, Vol. 64 No. 2, 2020.
Pregledni rad
https://doi.org/10.13112/PC.2020.13
SARS-CoV-2 infection (COVID-19) in children
Lorna Stemberger Marić
Srđan Roglić
Sažetak
Since the outbreak in December 2019, the SARS-CoV-2 pandemic virus has been a major public health problem in all countries of the
world. The virus is transmitted by inhalation of respiratory droplets from the patient or asymptomatic carrier and is highly contagious. The clinical disease in children is similar to any acute respiratory infection with predominant upper respiratory symptoms, but
occasionally can progress to pneumonia with acute respiratory distress syndrome and multiorgan failure. The disease is milder in
children than in adults, with low mortality, and it appears that infants and young children have a somewhat more severe clinical
course. Diagnosis is made by detecting the virus from respiratory samples (mainly nasopharyngeal and oropharyngeal swabs) using
polymerase chain reaction. Treatment is usually symptomatic, and in severe and critical forms, the use of one of the antiviral drugs
(lopinavir-ritonavir, remdesivir, hydroxychloroquine) may be considered.
Ključne riječi
: SARSCOV2; COVID19; CHILDREN; THERAPEUTICS
Hrčak ID:
243764
URI
Datum izdavanja:
25.6.2020.
Posjeta: 6.479 *